Clin2
NCT04913870Possibly a fitRecruiting

Tested blood pressure pills for mild to moderate aortic narrowing

Aortic StenosisAortic Valve Stenosis

Treatments studied

Part of Heart & circulation clinical trials.

This study tests whether angiotensin receptor blocker (ARB) blood pressure medication helps people with mild to moderate aortic stenosis (a narrowing of the heart’s main valve). It looks at safety and whether the treatment offers benefit for your heart and blood flow.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
144 people
Ages
20 years to 99 years
Study type
Interventional

Who can take part

  • You have mild to moderate aortic stenosis based on an echo test (jet speed between 2.5 and under 4 m/s)
  • Your heart’s pumping strength is normal (left ventricular ejection fraction at least 50%)
  • Your blood pressure is above set minimums (systolic over 110 and diastolic over 70)
  • You do not have more-than-mild leaks in the aortic or mitral valves, and you do not have mitral stenosis
  • You can take (and are not allergic to) ARB-type medications, and you are not already required to take similar “renin-angiotensin” medicines or aliskiren
  • You have kidney and liver health that is not severely reduced, and you are not pregnant or unable to consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02856620Recruiting
Study heart function and frailty in people with aortic valve narrowing

This study looks at how heart mechanics, blood markers, and frailty relate to symptoms and heart measurements in people with aortic stenosis (a stiff, narrowed heart valve). It may help doctors better understand who is at higher risk and how disease changes over time.

Montreal, Quebec
NCT04882488Recruiting
Testing heart scan measurements in severe aortic valve narrowing

This trial compares two pressure-based measurements of blood flow in the coronary arteries with a PET heart scan in people with severe aortic valve stenosis. It may help doctors choose the most accurate way to assess blood flow and guide care during valve treatment.

Bad Oeynhausen, North Rhine-Westphalia
NCT05851209Recruiting
Study biomarkers in people with moderate aortic valve narrowing

This study looks at blood and/or body signals (called biomarkers) to understand why aortic valve narrowing may worsen and what outcomes people have. You may be able to help researchers by undergoing regular heart care plus additional testing like MRI or CT if you qualify.

Bonn
NCT07539259Not yet recruiting· Phase 2
Drug study to reduce heart thickening in aortic stenosis

This study tests whether a combination of two drugs usually used for heart failure or diabetes can reduce thickening and scarring of the heart muscle in people with severe aortic stenosis after their valve is replaced. The goal is to help the heart recover more fully after the procedure.

NCT07690748Not yet recruiting
Remote monitoring for aortic stenosis

This trial tests whether remote monitoring with regular MRI scans can help manage aortic stenosis (a narrowed heart valve) in patients who don't have symptoms yet. The goal is to catch changes early and potentially delay or avoid the need for surgery.

NCT05991271Not yet recruiting
A new valve for a narrowed heart valve

This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.

Hear when a new Aortic Stenosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.